Neurocrine Biosciences Income Statement (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	296.00M	312.00M	310.60M	20.00M	387.90M	412.00M	420.40M	452.70M	498.80M	515.20M	515.30M	590.20M	622.10M	627.70M	572.60M	687.50M	794.90M	805.50M	814.50M	959.00M
Cost of Revenue (Quarter)	4.20M	4.10M	4.60M	4.80M	6.10M	7.70M	8.50M	11.50M	11.20M	8.50M	7.50M	9.20M	8.00M	9.30M	9.20M	11.30M	14.00M	17.60M	13.80M	23.20M
Gross Profit (Quarter)	291.80M	307.90M	306.00M	15.20M	381.80M	404.30M	411.90M	441.20M	487.60M	506.70M	507.80M	581.00M	614.10M	618.40M	563.40M	676.20M	780.90M	787.90M	800.70M	935.80M
Operating items
Amortization - Intangibles (Quarter)																1.00M				16.40M
Research & Development (Quarter)																				326.70M
Selling, General & Administrative (Quarter)																				439.70M
Other Operating Expenses (Quarter)	4.20M	104.40M	99.50M	110.70M	6.10M	7.70M	152.40M	11.50M	11.20M	8.50M	167.90M	195.30M	9.00M	12.30M		240.60M	14.30M	34.60M	28.60M
Operating Expenses (Quarter)																				807.50M
Operating Income (Quarter)																				151.50M
EBIT (Quarter)																				151.50M
Non-operating items
Interest & Investment Income (Quarter)																				12.40M
Other Non Operating Income (Quarter)				-70.00M
Non Operating Income (Quarter)																				10.70M
Net income details
EBT (Quarter)																				162.20M
Tax Provisions (Quarter)																				17.80M
Profit After Tax (Quarter)																				149.10M
Income from Non-Controlling Interests (Quarter)																				4.10M
Income from Continuing Operations (Quarter)																				144.40M
Consolidated Net Income (Quarter)																				144.40M
Income towards Parent Company (Quarter)																				144.40M
Net Income towards Common Stockholders (Quarter)																				144.40M
Additional items
EPS (Basic) (Quarter)																				1.43
EPS (Diluted) (Quarter)																				1.39
Shares Outstanding (Quarter)																				101.00M
Shares Outstanding (Diluted) (Quarter)																				104.20M
Shares Outstanding (Entity) (Quarter)																				101.60M
EBITDA (Quarter)																				151.50M
Interest Expenses (Quarter)																				583.10M
Tax Rate (Quarter)																				10.97%

Research Tools

Datasets

Plans

Developers

Neurocrine Biosciences NBIX Income Statement (2010-2026)

Research Tools

Datasets

Plans

Developers

Neurocrine Biosciences NBIX Income Statement (2010-2026)

Create an account

Sign In

Reset Password